Inability to cooperate with treatment protocol
Inability to comply with protocol-mandated hospitalization and activities restrictions
Inability to comply with requirements for cisplatin administration anti-emetic regimens post-treatment
Inability to comply with visit schedule or other protocol requirements.
Inability to cooperate with treatment protocol
Inability to comply with study requirements
Inability to comply with protocol requirements
Inability to comply with the protocol and/or not willing or not available for followup assessments
Inability to comply with treatment per investigator discretion
Inability to comply with protocol requirements
Inability to comply with treatment per investigator discretion
Inability to comply with protocol requirements
Inability to co-operate with the requirements of the protocol
Inability to comply with protocol requirements
Inability to give informed consent and comply with the protocol.
Inability to cooperate with the requirements of the protocol
Inability to comply with protocol requirements
Inability to comply with protocol requirements
Inability to comply with protocol requirements
Inability to comply with protocol requirements, including pharmacokinetic (PK) studies (phase I only) and genetic studies
Inability to comply with protocol requirements
Inability to practice contraception with condoms as prescribed by the protocol
Inability to comply with protocol requirements
Inability to co-operate with the requirements of the protocol
Inability to comply with study instructions
Inability to comply with protocol
High risk of inability to comply with transplant protocol, or inability to give appropriate informed consent in the estimation of the principal investigator (PI), social work, psychiatry, or the stem cell transplant team
Inability to comply with the treatment protocol or to undergo pre-specified follow-up tests for safety or effectiveness
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with other requirements of the protocol
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Inability to comply with protocol requirements
Inability to comply with IL-2 treatment regimen
Participants with inability to comply with IL-2 treatment regimen
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to co-operate with the requirements of the protocol
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with the protocol and/or not willing or not available for follow-up assessments
Inability to comply with the protocol and/or not willing or not available for follow-up assessments.
Inability to comply with protocol requirements
Inability to understand or comply with study protocol
Inability to comply with study requirements
Inability to comply with the protocol activities
inability to comply with the protocol activities
Sufficient mental capacity to comply with the protocol requirements,
Inability to comply with the study protocol.
Inability to comply with requirements of the protocol
Patients with the inability or with foreseeable incapacity, in the opinion of the Investigator, to comply with the protocol requirements.
Likely inability to comply with the protocol or cooperate fully with the investigator and site personnel
Patients with the inability, in the opinion of the Investigator, to comply with the protocol requirements
Inability to comply with protocol and/or not willing or not available for follow-up assessments
Known or suspected inability to comply with the study protocol.
Inability to comply with protocol requirements
Known or suspected inability to fully comply with study protocol.
Known or suspected inability to fully comply with study protocol
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
In the view of the investigator, the patient can and will comply with the requirements of the protocol.
Subjects who in the opinion of the Investigator will be unlikely to fully comply with protocol requirements.
Inability to comply with the pre-op diet
Inability to comply with protocol requirements including refusal to forego pre-procedural opioid use
Inability to comply with study requirement
Inability to comply with IL-2 treatment regimen
Has inability to give informed consent or comply with study requirements
Subjects who the investigator believes can and will comply with the requirements of the protocol.
Subjects who the investigator believes can and will comply with the requirements of the protocol
Inability to comply with protocol and/or not willing or not available for follow-up assessments
Inability to comply with protocol requirements
Inability to comply with the photosensitivity precautions associated with the study
inability to comply with the protocol
Inability to comply with instructions
Foreseen inability to comply with study requirements